Moderna
Biotechnology
Cambridge, Massachusetts
Private Corporation
Our Company
Moderna is a clinical stage pioneer of messenger RNA Therapeutics™, an entirely new in vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. This breakthrough platform addresses currently undruggable targets and offers a superior alternative to existing drug modalities for a wide range of diseases and conditions. Moderna is developing and plans to commercialize its innovative mRNA drugs through its own ventures and its strategic relationships with established pharmaceutical and biotech companies. Its current ventures are: Onkaido, focused on oncology, Valera, focused on infectious diseases, Elpidera, focused on rare diseases, and Caperna, focused on personalized cancer vaccines. Cambridge-based Moderna is privately held and currently has strategic agreements with AstraZeneca, Alexion Pharmaceuticals and Merck.Skills We're Looking For
Biotechnology
Pharmaceutical
Manufacturing
Biology
Molecular Biology
Biochemistry
Pharmacology
Knowledge of Cell Culture
Knowledge of RNA Isolation
Chemistry
Project Management
Technical Skill
Rigor
In vitro
Enzymology
Documentation
Human Immunology
Nucleic Acid
Subject Matter Expert
engineering
Current Good Manufacturing Practice (CGMP)
Bachelor of Science (BS)
Safety
Evaluating the Reliability and Validity of Biological Research Studies
Laboratory Methods and Techniques
Leadership
Product Evaluation
Techniques
Animal Studies
Bioassay
Enzyme-Linked Immunosorbent Assay
Western Blot
IntraCellular Cytokine Staining
Flow Cytometry
RT-PCR